Literature DB >> 3275869

Distinct binding sites for zinc and double-stranded RNA in the reovirus outer capsid protein sigma 3.

L A Schiff1, M L Nibert, M S Co, E G Brown, B N Fields.   

Abstract

By atomic absorption analysis, we determined that the reovirus outer capsid protein sigma 3, which binds double-stranded RNA (dsRNA), is a zinc metalloprotein. Using Northwestern blots and a novel zinc blotting technique, we localized the zinc- and dsRNA-binding activities of sigma 3 to distinct V8 protease-generated fragments. Zinc-binding activity was contained within an amino-terminal fragment that contained a transcription factor IIIA-like zinc-binding sequence, and dsRNA-binding activity was associated with a carboxy-terminal fragment. By these techniques, new zinc- and dsRNA-binding activities were also detected in reovirus core proteins. A sequence similarity was observed between the catalytic site of the picornavirus proteases and the transcription factor IIIA-like zinc-binding site within sigma 3. We suggest that the zinc- and dsRNA-binding activities of sigma 3 may be important for its proposed regulatory effects on viral and host cell transcription and translation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3275869      PMCID: PMC363116          DOI: 10.1128/mcb.8.1.273-283.1988

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  56 in total

1.  Studies on the structure of reovirus cores: selective removal of polypeptide lambda 2.

Authors:  C K White; H J Zweerink
Journal:  Virology       Date:  1976-03       Impact factor: 3.616

2.  Potential metal-binding domains in nucleic acid binding proteins.

Authors:  J M Berg
Journal:  Science       Date:  1986-04-25       Impact factor: 47.728

3.  Studies on the amino and carboxyl terminal amino acid sequences of reovirus capsid polypeptides.

Authors:  D M Pett; T C Vanaman; W K Joklik
Journal:  Virology       Date:  1973-03       Impact factor: 3.616

4.  Transcription by infectious subviral particles of reovirus.

Authors:  A J Shatkin; A J LaFiandra
Journal:  J Virol       Date:  1972-10       Impact factor: 5.103

5.  Studies on the effect of chymotrypsin on reovirions.

Authors:  W K Joklik
Journal:  Virology       Date:  1972-09       Impact factor: 3.616

6.  Complete nucleotide sequences of all three poliovirus serotype genomes. Implication for genetic relationship, gene function and antigenic determinants.

Authors:  H Toyoda; M Kohara; Y Kataoka; T Suganuma; T Omata; N Imura; A Nomoto
Journal:  J Mol Biol       Date:  1984-04-25       Impact factor: 5.469

Review 7.  The metallobiochemistry of zinc enzymes.

Authors:  B L Vallee; A Galdes
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1984

8.  Cleavage of the cap binding protein complex polypeptide p220 is not effected by the second poliovirus protease 2A.

Authors:  R E Lloyd; H Toyoda; D Etchison; E Wimmer; E Ehrenfeld
Journal:  Virology       Date:  1986-04-15       Impact factor: 3.616

9.  New intermediate subviral particles in the in vitro uncoating of reovirus virions by chymotrypsin.

Authors:  J Borsa; T P Copps; M D Sargent; D G Long; J D Chapman
Journal:  J Virol       Date:  1973-04       Impact factor: 5.103

10.  RNA-binding proteins of coronavirus MHV: detection of monomeric and multimeric N protein with an RNA overlay-protein blot assay.

Authors:  S G Robbins; M F Frana; J J McGowan; J F Boyle; K V Holmes
Journal:  Virology       Date:  1986-04-30       Impact factor: 3.616

View more
  49 in total

1.  Atomic structure of the major capsid protein of rotavirus: implications for the architecture of the virion.

Authors:  M Mathieu; I Petitpas; J Navaza; J Lepault; E Kohli; P Pothier; B V Prasad; J Cohen; F A Rey
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

2.  Structure of the reovirus membrane-penetration protein, Mu1, in a complex with is protector protein, Sigma3.

Authors:  Susanne Liemann; Kartik Chandran; Timothy S Baker; Max L Nibert; Stephen C Harrison
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

3.  RNA-binding activity of the rotavirus phosphoprotein NSP5 includes affinity for double-stranded RNA.

Authors:  Patrice Vende; Zenobia F Taraporewala; John T Patton
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Reovirus sigma NS protein localizes to inclusions through an association requiring the mu NS amino terminus.

Authors:  Cathy L Miller; Teresa J Broering; John S L Parker; Michelle M Arnold; Max L Nibert
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  Translational stimulation by reovirus polypeptide sigma 3: substitution for VAI RNA and inhibition of phosphorylation of the alpha subunit of eukaryotic initiation factor 2.

Authors:  R M Lloyd; A J Shatkin
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

6.  Proteolytic cleavage of the reovirus sigma 3 protein results in enhanced double-stranded RNA-binding activity: identification of a repeated basic amino acid motif within the C-terminal binding region.

Authors:  J E Miller; C E Samuel
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

7.  Genetic characterization of a new mammalian reovirus, type 2 Winnipeg (T2W).

Authors:  Jieyuan Jiang; Laura Hermann; Kevin M Coombs
Journal:  Virus Genes       Date:  2006-10       Impact factor: 2.332

8.  Evidence for zinc binding by two structural proteins of Plodia interpunctella granulosis virus.

Authors:  C J Funk; R A Consigli
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

9.  Characterization of a zinc blotting technique: evidence that a retroviral gag protein binds zinc.

Authors:  L A Schiff; M L Nibert; B N Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

10.  Reovirus polypeptide sigma 3 and N-terminal myristoylation of polypeptide mu 1 are required for site-specific cleavage to mu 1C in transfected cells.

Authors:  L Tillotson; A J Shatkin
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.